 "Top headlines: Sebi chief speaks on IPO valuations; Omicron spreads")
As the Omicron coronavirus variant spread around the world on Sunday, experts said developing antivirals is the way forward to combat the disease. More on that story in our top headlines.
New Covid-19 variant: Antivirals hold the key as mutations surface
New Covid-19 variant: Antivirals hold the key as mutations surface
With Omicron appearing on the scene as the new variant of concern, experts say developing antivirals is the way forward to combat Covid in the long run.
If the ever-mutating virus keeps evading the vaccine-induced immunity, one can think of next-generation Covid vaccines, but it is antivirals that hold the key to combating the virus, say scientists. Read more
Sebi won't interfere with IPO valuations, says chairman
Ajay Tyagi’s four-year-and-nine-month stint as chairman of market watchdog Securities and Exchange Board of India (Sebi) has been largely successful. In an exclusive interview with Samie Modak, Tyagi shares his views on various issues concerning the markets. Read more
Start-up pay cheques, ESOPs create new breed of angel investors
The profile of the typical angel investor - someone who bets on early stage start-ups - is changing. It was always an HNI or founder or CXO of a start-up who had made money on big bang exits. Read more
Fintech start-up slice turns India's 41st unicorn in 2021
Fintech start-up slice has raised $220 million in a Series B round that values the company at over $1 billion, making it the latest entrant to India’s coveted unicorn club. Read more
Why Rakesh Jhunjhunwala's Akasa Air could prove the sceptics wrong
At the recently concluded Dubai airshow, Akasa, Rakesh Radheyshyam Jhunjhunwala’s new airline, signed a $9 billion deal with American aircraft maker Boeing to buy its 737 MAX planes and a $4 billion one for engines with CFM, a joint venture between GE of the US and Safran of France. Read more
One subscription. Two world-class reads.
Already subscribed? Log in
Subscribe to read the full story →*Subscribe to Business Standard digital and get complimentary access to The New York Times
Smart Quarterly
₹900
3 Months
₹300/Month
SAVE 25%
Smart Essential
₹2,700
1 Year
₹225/Month
SAVE 46%
*Complimentary New York Times access for the 2nd year will be given after 12 months
Super Saver
₹3,900
2 Years
₹162/Month
Subscribe
Renews automatically, cancel anytime
Here’s what’s included in our digital subscription plans
Exclusive premium stories online
Over 30 premium stories daily, handpicked by our editors
Complimentary Access to The New York Times
News, Games, Cooking, Audio, Wirecutter & The Athletic
Business Standard Epaper
Digital replica of our daily newspaper — with options to read, save, and share
Curated Newsletters
Insights on markets, finance, politics, tech, and more delivered to your inbox
Market Analysis & Investment Insights
In-depth market analysis & insights with access to The Smart Investor
Archives
Repository of articles and publications dating back to 1997
Ad-free Reading
Uninterrupted reading experience with no advertisements
Seamless Access Across All Devices
Access Business Standard across devices — mobile, tablet, or PC, via web or app
SAVE 25%